Chicago Atlantic Real Estate Finance Delivers Strong Q3 Dividend News
Chicago Atlantic Real Estate Finance Announces Strong Dividend
Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a prominent commercial mortgage real estate investment trust, recently made an exciting announcement regarding its financial growth. The company's board of directors has declared a regular quarterly cash dividend of $0.47 per share for its third quarter. This is an impressive continuation of efforts to reward shareholders as the company builds on its success.
Quarterly Dividend Highlights
The dividend of $0.47 per share represents a notable annualized rate of $1.88 per common share. It demonstrates Chicago Atlantic's commitment to maintaining a steady return for its investors. The dividend is slated to be paid on a specific upcoming date to all shareholders who are on record as of a predetermined cutoff, reflecting a well-organized payment schedule that promotes reliability and trust among investors.
Understanding the Company’s Financial Strategy
Chicago Atlantic Real Estate Finance focuses on leveraging its extensive expertise across real estate, credit, and cannabis sectors. The company specializes in originating senior secured loans, primarily to state-licensed cannabis operators. Operating within limited-license states allows the company to navigate the complexities of the industry while ensuring substantial financial backing. With over $2.2 billion already deployed in credit and equity investments, REFI is in a robust position to continue its growth trajectory.
Strategic Growth and Market Leadership
Chicago Atlantic is part of a larger platform that showcases its market-leading position. With offices strategically located in key areas, including Miami and Chicago, the company is well-positioned to capitalize on opportunities in the growing cannabis sector. The management's strategy emphasizes building a diversified portfolio that mitigates risks while maximizing yields, which is critical in today's evolving financial landscape.
Contact Information for Further Inquiries
For more insights or inquiries, interested parties can reach out through various channels. The main contact point for investor relations is Tripp Sullivan at SCR Partners. Investors can also conveniently contact the company via email for direct communication. This accessibility reflects the company's commitment to transparency and investor relations.
Frequently Asked Questions
What is the declared dividend amount for Q3 2024?
The declared dividend amount for Q3 2024 is $0.47 per share.
When will the dividend be paid?
The dividend is set to be paid on a specified date to shareholders of record.
What is Chicago Atlantic’s primary focus in the real estate sector?
The primary focus of Chicago Atlantic is to provide secured loans mainly to state-licensed cannabis operators.
How much investment has Chicago Atlantic made to date?
Chicago Atlantic has deployed over $2.2 billion in credit and equity investments to date.
Who can I contact for further inquiries about the company?
For further inquiries, you can contact Tripp Sullivan at SCR Partners or email the company's investor relations.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- CVB Financial Corp. Rewards Shareholders with 140th Dividend
- APA Corporation Announces Exciting Cash Dividend for Shareholders
- CVB Financial Corp. Declares 140th Quarterly Dividend Payment
- Understanding APA Corporation's Recent Cash Dividend Decision
- Assessing the Value of Invesco Dividend Achievers ETF Today
- How GPARENCY’s Innovative Brokerage Model is Transforming Real Estate
- Viatris Set to Share Q3 2024 Performance Insights Soon
- Xenia Hotels & Resorts Announces Third Quarter 2024 Dividend
- Fathom Realty's $2.95 Million Settlement: A Strategic Move
- Cleveland-Cliffs Secures Stelco Acquisition with Strong Backing
Recent Articles
- Circle Pharma Welcomes New Leaders to Enhance Drug Discovery
- EyePoint Pharmaceuticals Announces Inducement Awards for New Team Members
- Data Vault Holdings, Inc. Showcases Innovation at NYSDS 2024
- Southwest Airlines Celebrates Ratification of Labor Contracts
- Unicycive Therapeutics Set to Share Updates at Investor Forum
- Innovative Cytokine Solution Revolutionizes CAR-T Therapy Production
- Social Media Sparks Theories Following Trump Incident
- Nuvalent Launches $350 Million Public Offering for Growth
- Market Movements: Gold Gains Amid Dollar Weakening
- Broadridge Launches Revolutionary Platform for Asset Servicing
- Celebrating 90 Years of Lupin Lodge: A Legacy in Naturism
- Find Therapeutics Secures $8.1 Million for FTX-101 Development
- Empowering College Students Through Safe Dating Initiatives
- Legal-Bay Expands Services to Assist California Lawsuit Plaintiffs
- Lingerfelt Celebrates Full Occupancy at Ashton Logistics Park
- Univation's Technology Choice Impacts IOCL's PE Production Plans
- Three Women at Quantix Honored with Supply Chain Awards
- Innovative Cancer Treatment Unveiled by PhytoHealth Corporation
- Exciting New Franchise Opportunity for Tint World in Wisconsin
- Gogo Business Aviation and Airshare Unite for Enhanced Connectivity
- WaverBed's Latest Innovation: The Transformative WaverMat
- Vizsla Silver Secures $65 Million Financing for Expansion
- Domino's Introduces 5-Cheese Mac & Cheese for Fall Enjoyment
- FANUC Corp Faces Mixed Review Amidst Market Reassessments
- Yelp Faces Headwinds from Competition Despite Recent Growth
- Mosaic Company Faces Production Challenges and Strategic Changes
- TriSalus Life Sciences Shows Promise with Cancer Treatment Tech
- Metcash Stock Sees Positive Growth Amid Industry Changes
- Truist Elevates Builders FirstSource Rating Amid Growth Prospects
- AutoZone: Strategies for Growth Amidst Market Challenges
- JPMorgan Ups Rating for Northern Star Resources: What's Next?
- Understanding Market Reactions Ahead of Fed Interest Rate Changes
- Investors React to Hemlo Explorers' Promising Project Update
- Identifying Bargains: Analyzing Overlooked Stocks Today
- Exploring Michael Saylor's Bitcoin Predictions and Strategy
- LIS Technologies Welcomes Keith Everly as Security Chief
- Market Anticipation Grows Ahead of Fed's Decision Next Week
- Advancements in Dermatologic Surgery: ASDS Hosts Innovative Course
- VEON's Commitment to Ukraine: Investment and Growth Insights
- Can-Fite Advances Pancreatic Cancer Treatment with New Study
- Battery-Operated Smoke Detectors to Surpass $5 Billion by 2034
- D.O.G.E Shines Bright: A New Era of Memecoins Emerges
- Crypto Plus: Empowering the Global Cryptocurrency Community
- Leadership Changes at Lantronix: Strategic Transition Ahead
- Revolutionary Mpox Vaccine Candidate By Tonix Gains Support
- Zentalis Pharmaceuticals Celebrates FDA Approval to Resume Azenosertib Trials
- Critical Metals Corp: Driving Innovation in Lithium Supply Chains
- Nayax and Adyen's Strategic Partnership Set to Transform EV Payments
- WisdomTree Issues Notice on ETP Securities Threshold Changes
- ANI Pharmaceuticals Moves Forward with Alimera Acquisition